Zentalis Pharmaceuticals Statistics
Total Valuation
ZNTL has a market cap or net worth of $253.52 million. The enterprise value is -$195.53 million.
| Market Cap | 253.52M |
| Enterprise Value | -195.53M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ZNTL has 71.01 million shares outstanding. The number of shares has increased by 20.10% in one year.
| Shares Outstanding | 71.01M |
| Shares Change (YoY) | +20.10% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 3.99% |
| Owned by Institutions (%) | 120.74% |
| Float | 51.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.25 |
| Forward PS | n/a |
| PB Ratio | 0.55 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.19, with a Debt / Equity ratio of 0.09.
| Current Ratio | 9.19 |
| Quick Ratio | n/a |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.10% and return on invested capital (ROIC) is -51.72%.
| Return on Equity (ROE) | -46.10% |
| Return on Assets (ROA) | -37.80% |
| Return on Capital (ROIC) | -51.72% |
| Revenue Per Employee | $327,097 |
| Profits Per Employee | -$1.77M |
| Employee Count | 124 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -566,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.38% in the last 52 weeks. The beta is 1.83, so ZNTL's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | -87.38% |
| 50-Day Moving Average | 9.97 |
| 200-Day Moving Average | 13.52 |
| Relative Strength Index (RSI) | 18.78 |
| Average Volume (20 Days) | 2,757,227 |
Short Selling Information
The latest short interest is 17.84 million, so 25.13% of the outstanding shares have been sold short.
| Short Interest | 17.84M |
| Short Previous Month | 17.51M |
| Short % of Shares Out | 25.13% |
| Short % of Float | 34.64% |
| Short Ratio (days to cover) | 28.69 |
Income Statement
In the last 12 months, ZNTL had revenue of $40.56 million and -$218.96 million in losses. Loss per share was -$3.33.
| Revenue | 40.56M |
| Gross Profit | 40.56M |
| Operating Income | -259.32M |
| Pretax Income | -219.53M |
| Net Income | -218.96M |
| EBITDA | -218.17M |
| EBIT | -219.53M |
| Loss Per Share | -$3.33 |
Balance Sheet
The company has $491.67 million in cash and $42.62 million in debt, giving a net cash position of $449.05 million or $6.32 per share.
| Cash & Cash Equivalents | 491.67M |
| Total Debt | 42.62M |
| Net Cash | 449.05M |
| Net Cash Per Share | $6.32 |
| Equity (Book Value) | 458.77M |
| Book Value Per Share | 6.46 |
| Working Capital | 449.01M |
Cash Flow
In the last 12 months, operating cash flow was -$210.51 million and capital expenditures -$623,000, giving a free cash flow of -$211.14 million.
| Operating Cash Flow | -210.51M |
| Capital Expenditures | -623,000 |
| Free Cash Flow | -211.14M |
| FCF Per Share | -$2.98 |
Margins
Gross margin is 100.00%, with operating and profit margins of -639.35% and -539.84%.
| Gross Margin | 100.00% |
| Operating Margin | -639.35% |
| Pretax Margin | -541.24% |
| Profit Margin | -539.84% |
| EBITDA Margin | -537.90% |
| EBIT Margin | -541.24% |
| FCF Margin | -520.55% |
Dividends & Yields
ZNTL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.10% |
| Shareholder Yield | -20.10% |
| Earnings Yield | -86.37% |
| FCF Yield | -83.28% |
Analyst Forecast
The average price target for ZNTL is $13.14, which is 268.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.14 |
| Price Target Difference | 268.07% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -29.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ZNTL has an Altman Z-Score of -0.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.93 |
| Piotroski F-Score | 3 |